TY -非盟的陈蜀AU -锣,羡慕盟——Kazi Dhruv年代AU -盖茨,安B非盟-巴姨,荣AU - Fu,华盟——彭Weixia AU - De La Cruz,金妮AU -陈,Lei盟——刘,仙霞AU - Su,清洁盟——Girerd尼古拉斯盟——Karaye Kamilu M盟——Alhabib Khalid F AU - Yan冯丽静L盟——Schwalm JD PY - 2018 DA - 2018/01/25 TI -使用移动健康干预提高冠心病二级预防的疾病在中国:混合方法可行性研究JO - JMIR Mhealth Uhealth SP - e9 VL - 6 IS - 1kw -冠心病KW -二级预防KW -药物依从性KW -移动应用KW -短信AB -背景:冠心病(CHD)是全球心血管死亡的主要原因，但基于证据的二级预防策略的实施仍然不理想。目的:本研究旨在评估可行性，特别是可用性和可接受性，并评估针对医生和患者的移动健康(mHealth)干预的初步有效性，以提高循证药物的依从性和生活方式的改变。方法:我们在中国上海和海南的两个地点进行了一项为期12周的前期干预试点研究。医生使用本研究中设计的应用程序开具循证药物并记录患者信息。符合条件和同意的患者在12周内每周收到4至5次自动短信或语音电话，以了解药物依从性和健康行为。在两个地点对10名医生和24名患者进行了访谈，以了解他们对药物依从性的看法以及对可用性和可接受性的反馈。在患者随访调查中也询问了可用性和可接受性问题。关于评估有效性，主要结果是12周时的药物依从性(根据Morisky Green Levine量表估计)。次要结果包括身体活动、吸烟状况、水果和蔬菜消费以及设施访问频率。 Results: Interview findings and patient survey showed the good usability and acceptability of the intervention. Among 190 patients who completed the intervention, there was a significant increase in medication adherence (odds ratio [OR] 1.80, 95% CI 1.14-2.85). The study also showed decrease of smokers’ percentage (−5%, P=.05), increase of daily vegetables consumption frequency (+0.3/day, P=.01), and community health care center visit frequency (+3 in 3 months, P=.04). The following site-specific differences were noted: medication adherence appeared to increase in Hainan (OR 14.68, 95% CI 5.20-41.45) but not in Shanghai (OR 0.61, 95% CI 0.33-1.12). Conclusions: Our study demonstrated that the intervention was feasible in both a tertiary care center and an urban community health center in China. Preliminary results from pre-post comparison suggest the possibility that provider and patient-linked mHealth interventions may improve medication adherence and lifestyle modifications among CHD patients, especially in resource-scarce settings. Randomized controlled trials are needed to verify the findings. SN - 2291-5222 UR - http://mhealth.www.mybigtv.com/2018/1/e9/ UR - https://doi.org/10.2196/mhealth.7849 UR - http://www.ncbi.nlm.nih.gov/pubmed/29371178 DO - 10.2196/mhealth.7849 ID - info:doi/10.2196/mhealth.7849 ER -